Table II.
Chemotherapy regimen | Patient number | pCR number | pCR rate (%) |
---|---|---|---|
EC → TXT | 5 | 0 | 0 |
EC → TXT + H | 2 | 0 | 0 |
TMC | 16 | 1 | 6 |
TEC + H | 11 | 2 | 18 |
TEC | 60 | 17 | 28 |
TMC + H | 6 | 2 | 33 |
PERT/H/TXT | 17 | 13 | 76 |
EC, Epirubicin + Cyclophosphamide; TXT, Taxotere; H, Herceptin (Trastuzumab); TMC, Docetaxel + Myocet (liposomal doxorubicin) + Cyclophosphamide; TEC, Docetaxel + Epirubicin + Cyclophosphamide; PERT, Pertuzumab.